ArticleEClinicalMedicine2026

Safety and pharmacokinetics of sulfasalazine and its metabolite sulfapyridine for treatment of preterm preeclampsia in Australia (SIP): an early phase, unblinded, single-arm, proof of concept clinical trial.

Elif Kadife et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.